Dyne Therapeutics Stock Predictions

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio

Sell

DYN
Dyne Therapeutics

Last Price:

$11.89

Seasonality Move:

39.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Could BOXABL Be the Tesla of Housing?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Dyne Therapeutics Stock Forecast

Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 28.7% based on the past 4 years of stock performance.
Dyne Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Dyne Therapeutics Stock Undervalued?

The current Dyne Therapeutics [DYN] share price is $11.90. The Score for DYN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
DYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Dyne Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 28.7% based on the past 4 years of stock performance.

Dyne Therapeutics Stock Rating

Sell

Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics overpriced?

Dyne Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Dyne Therapeutics Stock Price History

Is DYN stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DYN is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

dyne-tx.com

52-Week Data

52-Week High:

47.45

52-Week Low:

6.36

Prediction Charts

Market Cap:

1.4B

Price in USD:

11.90

Volume:

1.7M

Beta:

1.19

Technical Analysis

SMA50:

10.61

SMA100:

13.29

SMA200:

23.62

52-Wk Change:

-62.26%

Stock Predictions

Is Dyne Therapeutics stock public?

Yes, Dyne Therapeutics is a publicly traded company.
What is the Dyne Therapeutics stock quote today?

The Dyne Therapeutics stock price is 11.90 USD today.
How to buy Dyne Therapeutics stock online?

You can buy Dyne Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-5	11.70	11.83	11.97	11.33
May-6	11.74	10.02	11.74	9.97
May-7	10.10	9.40	10.12	9.17
May-8	9.58	11.30	11.78	9.26
May-9	11.44	11.41	12.01	11.18
May-12	12.12	12.56	13.03	11.64
May-13	12.73	12.10	12.86	11.77
May-14	12.09	11.70	12.29	11.17
May-15	11.58	11.74	11.83	11.19
May-16	11.77	11.83	12.09	11.56
May-19	11.51	11.66	11.88	11.22
May-20	11.60	12.34	12.36	11.45
May-21	12.07	11.76	12.17	11.44
May-22	11.63	11.90	12.45	11.54

Dyne Therapeutics Earnings

Dyne Therapeutics Earnings Report: Per Share Dyne Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Dyne Therapeutics Forecast Revenue Growth

Dyne Therapeutics Stock Analysis: Historical quarterly revenues per share for Dyne Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.44 per share, and an increase next year of $0.14 per share.

* Dyne Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.